3-319864-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000256509.7(CHL1):āc.88T>Gā(p.Ser30Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00205 in 1,559,796 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0089 ( 19 hom., cov: 32)
Exomes š: 0.0013 ( 25 hom. )
Consequence
CHL1
ENST00000256509.7 missense
ENST00000256509.7 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
CHL1 (HGNC:1939): (cell adhesion molecule L1 like) The protein encoded by this gene is a member of the L1 gene family of neural cell adhesion molecules. It is a neural recognition molecule that may be involved in signal transduction pathways. The deletion of one copy of this gene may be responsible for mental defects in patients with 3p- syndrome. This protein may also play a role in the growth of certain cancers. Alternate splicing results in both coding and non-coding variants. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0055780113).
BP6
Variant 3-319864-T-G is Benign according to our data. Variant chr3-319864-T-G is described in ClinVar as [Benign]. Clinvar id is 767882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00894 (1360/152136) while in subpopulation AFR AF= 0.03 (1245/41546). AF 95% confidence interval is 0.0286. There are 19 homozygotes in gnomad4. There are 656 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHL1 | NM_006614.4 | c.88T>G | p.Ser30Ala | missense_variant | 3/28 | ENST00000256509.7 | NP_006605.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHL1 | ENST00000256509.7 | c.88T>G | p.Ser30Ala | missense_variant | 3/28 | 1 | NM_006614.4 | ENSP00000256509 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00885 AC: 1345AN: 152018Hom.: 19 Cov.: 32
GnomAD3 genomes
AF:
AC:
1345
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00289 AC: 706AN: 243914Hom.: 9 AF XY: 0.00279 AC XY: 368AN XY: 131956
GnomAD3 exomes
AF:
AC:
706
AN:
243914
Hom.:
AF XY:
AC XY:
368
AN XY:
131956
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00130 AC: 1834AN: 1407660Hom.: 25 Cov.: 23 AF XY: 0.00140 AC XY: 983AN XY: 703088
GnomAD4 exome
AF:
AC:
1834
AN:
1407660
Hom.:
Cov.:
23
AF XY:
AC XY:
983
AN XY:
703088
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00894 AC: 1360AN: 152136Hom.: 19 Cov.: 32 AF XY: 0.00882 AC XY: 656AN XY: 74362
GnomAD4 genome
AF:
AC:
1360
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
656
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
103
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
437
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;.
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;.
Sift4G
Benign
T;T;T;T;T;T;T
Polyphen
B;B;.;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at